Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

BACKGROUND: Use of rate/rhythm control is essential to control symptoms in patients with atrial fibrillation (AF). Recently, the EAST-AFNET 4 trial described how early rhythm control strategy was associated with a lower risk of adverse clinical outcomes. OBJECTIVES: The aim was to evaluate the real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Proietti, Marco, Vitolo, Marco, Harrison, Stephanie L., Lane, Deirdre A., Fauchier, Laurent, Marin, Francisco, Nabauer, Michael, Potpara, Tatjana S., Dan, Gheorghe-Andrei, Boriani, Giuseppe, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766399/
https://www.ncbi.nlm.nih.gov/pubmed/34448931
http://dx.doi.org/10.1007/s00392-021-01914-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766399/
https://www.ncbi.nlm.nih.gov/pubmed/34448931
http://dx.doi.org/10.1007/s00392-021-01914-y

Ejemplares similares